Financials in USD. Standardized financial statements.
A compact view of how CONMED Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B | $862.46M | $955.10M | $859.63M | $796.39M | $763.52M |
| Revenue Growth? | +5.2% | +5.0% | +19.1% | +3.4% | +17.2% | -9.7% | +11.1% | +7.9% | +4.3% | 0.0% |
| Cost of Revenue? | $649.12M | $573.98M | $568.50M | $474.23M | $442.60M | $402.16M | $430.38M | $390.52M | $365.35M | $355.19M |
| Gross Profit? | $725.38M | $733.03M | $676.25M | $571.25M | $568.04M | $460.30M | $524.72M | $469.11M | $431.04M | $408.33M |
| Gross Margin? | +52.8% | +56.1% | +54.3% | +54.6% | +56.2% | +53.4% | +54.9% | +54.6% | +54.1% | +53.5% |
| Operating Expenses? | $584.24M | $532.71M | $555.64M | $501.19M | $458.32M | $414.29M | $445.60M | $397.81M | $384.11M | $370.65M |
| Operating Income? | $141.13M | $200.33M | $120.60M | $70.05M | $109.72M | $46.01M | $79.11M | $71.31M | $46.94M | $37.68M |
| EBITDA? | $193.47M | $272.18M | $192.48M | $7.80M | $179.33M | $118.28M | $146.25M | $133.11M | $105.48M | $90.04M |
| Income Before Tax | $71.12M | $163.03M | $80.83M | -$70.86M | $73.11M | $1.60M | $31.23M | $50.65M | $28.73M | $19.38M |
| Income Tax Expense | $24.06M | $30.61M | $16.37M | $9.72M | $10.56M | -$7.91M | $2.60M | $9.80M | -$26.75M | $4.71M |
| Net Income? | $47.05M | $132.42M | $64.46M | -$80.58M | $62.54M | $9.52M | $28.62M | $40.85M | $55.49M | $14.66M |
| EPS? | $1.52 | $4.29 | $2.10 | $-2.68 | $2.14 | $0.33 | $1.01 | $1.45 | $1.99 | $0.53 |
| Diluted EPS? | $1.51 | $4.26 | $2.04 | $-2.68 | $1.94 | $0.32 | $0.97 | $1.41 | $1.97 | $0.52 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality